ARTICLE | Clinical News
Avastin bevacizumab regulatory update
May 4, 2009 7:00 AM UTC
The U.K.'s NICE issued a final appraisal determination (FAD) recommending against the use of 4 drugs to treat advanced and/or metastatic renal cell carcinoma (RCC). The FAD evaluated Avastin bevacizum...